Call for Abstracts

Only poster presentation will be available for submission. Accepted submissions will be displayed everyday through the meeting.
Case report written in English will also be welcome, especially using molecular targeting drugs, management of adverse events, and oncologic emergencies.

Period for Abstract Submission

February 16 (Fri) - March 30 (Fri), 2018
Deadline extended to: Noon April 25(Wed), 2018

• The system will automatically close after the above date. Corrections, registrations and deleting of the abstracts will not be allowed after the deadline.
• Please submit your abstract well in advance to avoid unforeseen circumstances as access concentration is expected just before the deadline.

Congress Secretariat

c/o Sunplanet Co.,Ltd.
6F Sumitomo seisen koishikawa Bldg.,
3-5-10 Otsuka, Bunkyo-ku, Tokyo
112-0012, Japan
E-mail: actj@sunpla-mcv.com